New Delhi: Corona is seen once again showing his form of grief across the country. Corona cases are on the rise and in the meantime some states have expressed concern over the vaccine not being available. A big announcement was made on this by the Central Government on Friday.
The government says that the current production capacity of indigenously developed covaccine will be doubled by May-June 2021 and will then increase by about 6-7 times by July-August 2021. The country has been recording a record increase in COVID-19 infections in the last few weeks.
In an effort to accelerate the development and production of indigenous COVID-19 vaccines under the mission, the government will provide financial assistance in the form of grants to vaccine manufacturing facilities for increased production capacity.
According to ANI news, the Ministry of Science and Technology said, production will be increased from one crore vaccine doses in April 2021 to 6-7 million vaccine doses per month in July-August. It is expected to reach around 10 crore doses per month by September this year.
Three public sector companies are being supported to increase vaccine production capacity. The government is supporting Bharat Biotech’s Hafekin Biopharmaceutical Corporation Limited, Indian Immunological Limited (IIL), Hyderabad-National Dairy Development Board and Bharat Immunological and Biological Limited (BIBCOL) in Mumbai.
Bharat Biotech’s new Bangalore facility is being provided with financial assistance of around Rs 65 crore, which is being supported to increase vaccine production capacity.
The company sought approximately 12 months to complete this task. However, the central government has asked them to expedite the work and complete the work immediately within 6 months. Once functional, you will get 2 crore doses per month.
The statement said that Indian Immunological Limited (IIL) in Hyderabad will also be supported to provide 10 to 20 lakh doses per month.